News

WE LIKE TO KEEP YOU UPDATED

Centroflora CMS Enters an Exclusive Agreement to Distribute N-Butyl Scopolamine Globally

Boehringer Ingelheim awards Centroflora CMS the exclusive distribution rights for N-Butyl Scopolamine (SNBB) globally. This decision demonstrates and fully aligns with Boehringer Ingelheim long-term commitment to remain a key manufacturer of SNBB while Centroflora CMS is to assume market supply responsibilities as of January 1, 2015.